Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
The company increases its efficiency and is able to face the growing demand for its services.
Campaign to celebrate World Mental Health Day theme "Mental Health in an Unequal World"
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
This win is on the back of a prestigious order from Reliance Life Sciences
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
Subscribe To Our Newsletter & Stay Updated
